March 20, 2026，Edge Medical's multi-port surgical robotic system has completed commercial installation and entered clinical use at Hospital Orizonti, a premier private comprehensive hospital in Minas Gerais. This represents the first multi-port surgical robot to become operational in southeastern Brazil and marks the second commercial installation completed by the company in Brazil during Q1 2026, signaling accelerated progress in localization strategy. 🏥 Premier Healthcare Institution Adopts Cutting-Edge Technology Hospital Orizonti, part of the leading Brazilian healthcare group Grupo Orizonti, serves as a benchmark for modernized medicine in the state. In its inaugural clinical application, urologic specialists Dr. Mateus Furtado Rocha and Dr. Leonardo Gomes Lopes successfully completed three radical prostatectomy cases with seamless and stable surgical workflows throughout the procedures. Surgeon Testimonials:The multi-port robotic system demonstrated exceptional operational fluency and stability. The master console and foot pedal design optimize ergonomics, eliminating fatigue even during extended surgical sessions. 🎯 Addressing Critical Clinical Needs Through Precision Medicine According to Brazil's National Cancer Institute (INCA), approximately 704,000 new cancer cases are diagnosed annually in Brazil between 2023 and 2025, with prostate and breast cancer maintaining persistently high incidence rates. The introduction of surgical robotic technology is emerging as a key force for elevating cancer treatment capabilities nationwide.   Hospital leadership emphasized that integrating the Edge Medical multi-port surgical robotic system represents a significant milestone in the hospital's development trajectory. This advancement will substantially enhance diagnostic and treatment capabilities, offering tangible hope to cancer patients through precision-driven surgical interventions. 📈  Accelerating Local Deployment Strategy, Deepening Latin America Market Penetration The Edge Medical multi-port surgical robotic system obtained Brazil's ANVISA regulatory certification in 2025. Brazil's first commercial installation was deployed at Scolla, one of Latin America's largest surgical training centers. Building on this momentum, the company has completed two additional commercial installations in the first quarter of 2026 at Unimed João Pessoa, a benchmark hospital in São Paulo state, and Hospital Orizonti in Minas Gerais, demonstrating efficient commercial execution pace. 🤝We have established a comprehensive service ecosystem covering market promotion, clinical training, and technical support across Latin America, ensuring that Edge Medical's multi-port surgical robotic system achieves sustainable and efficient commercial deployment in the Brazilian market.